ICON Strengthens Its Bioanalytical Sciences Group

ICON has strengthened its Bioanalytical Sciences team following the acquisitions of Prevalere Life Sciences (Prevalere) and Veeda Laboratories (Veeda) with the appointment of Dr. Ray Briggs as vice president of LC/MS Services. He will oversee the bioanalytical (small molecule) services of ICON globally.

In addition to that, the company has also appointed several other members to strengthen its Bioanalytical Sciences team. Reportedly, Mario Rocci has taken the charge of executive vice president and will oversee ICON’s globally expanding Bioanalytical Sciences group, incorporating LC/MS/MS, immunoassay and biomarker service offerings.

Dr. Paula Jardieu has been appointed as a senior vice president and will lead the global immunoassay and immunogenicity services for ICON.

Further, John Allinson, vice president, will head the global laboratory biomarkers group within ICON Development Solutions and brings over 37 years of experience in developing and working with novel biomarkers for use in drug development across all therapeutic categories and phases of development.

Thomas Frey, president of ICON Development Solutions, said: “We are very excited about the new global senior management team leading our bioanalytical sciences group. With the increasing focus on adaptive design in early phase research and seamless delivery throughout the drug development cycle, our team of experts can work with clients to speed the development of novel medicines.”